Johnson & Johnson announced that it has received European CE Mark approval for its new Ethicon 4000 Stapler, an advanced surgical stapler designed to deliver reliable staple line integrity across a wide range of tissue thickness.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Johnson & Johnson to showcase electrophysiology portfolio at HRS meeting
- Johnson & Johnson price target raised to $266 from $244 at Guggenheim
- JPMorgan ups CG Oncology target, adds ‘Positive Catalyst Watch’
- Johnson & Johnson’s Stelara gets FDA approval for added indication
- Trump names Erica Schwartz CDC Director